Markku Qvarnström
Harvard University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Markku Qvarnström.
Circulation | 2004
Sok-Ja Janket; Markku Qvarnström; Jukka H. Meurman; Alison E. Baird; Pekka Nuutinen; Judith A. Jones
Background—Oral infections have been postulated to produce cytokines that may contribute to the pathogenesis of coronary heart disease (CHD). We hypothesized that by estimating the combined production of inflammatory mediators attributable to several oral pathologies, we might be able to explain CHD with better precision. Methods and Results—A total of 256 consecutive Finnish cardiac patients from Kuopio University Hospital with angiographically confirmed CHD and 250 age-, gender-, and residence-matched noncardiac patients (controls) were recruited. All dental factors expected to generate inflammatory mediators, including pericoronitis, dental caries, dentate status, root remnants, and gingivitis, were examined, and an asymptotic dental score (ADS) was developed by logistic regression analyses with an appropriate weighting scheme according to the likelihood ratio. We validated the explanatory ability of ADS by comparing it to that of the Total Dental Index and examining whether the ADS was associated with known predictors of CHD. A model that included ADS, C-reactive protein, HDL, and fibrinogen offered an explanatory ability that equaled or exceeded that of the Framingham heart score (C statistic=0.82 versus 0.80). When ADS was removed from this model, the C-statistic decreased to 0.77, which indicates that the ADS was a significant contributor to the explanatory ability of a logistic model. Conclusions—ADS may be useful as a prescreening tool to promote proactive cardiac evaluation among individuals without overt symptoms of CHD. However, additional prospective study is needed to validate the use of an oral health score as a predictor of incident CHD.
Journal of Clinical Periodontology | 2010
Markku Qvarnström; Sok-Ja Janket; Judith A. Jones; Kamal Jethwani; Pekka Nuutinen; Raul I. Garcia; Alison E. Baird; Thomas E. Van Dyke; Jukka H. Meurman
INTRODUCTION Salivary lysozyme (SLZ) is a proteolytic enzyme secreted by oral leucocytes and contains a domain that has an affinity to advanced glycation end products (AGE). Thus, we hypothesized that SLZ would be associated with metabolic syndrome (metS), a pro-inflammatory state. METHODS Utilizing cross-sectional data from 250 coronary artery disease (CAD) and 250 non-CAD patients, the association of SLZ with metS was tested by logistic regression analyses controlling for age, sex, smoking, total cholesterol and C-reactive protein (CRP) levels. The analyses were stratified by CAD status to control for the possible effects of CAD. RESULTS MetS was found in 122 persons. The adjusted odds ratio (OR) for metS associated with the highest quartile of SLZ was 1.95 with 95% confidence interval (CI) 1.20-3.12, p-value=0.007, compared with the lower three quartiles combined. Among the 40 subjects with metS but without CAD, the OR was 1.63 (CI: 0.64-4.15, p=0.31), whereas in the CAD group, SLZ was significantly associated with metS [OR=1.96 (1.09-3.52), p=0.02]. In both subgroups, CRP was not significantly associated with metS. CONCLUSION SLZ was significantly associated with metS (OR=1.95) independent of CRP level. Future longitudinal research is warranted.
Journal of Dental Research | 2010
Sok-Ja Janket; Jukka H. Meurman; Alison E. Baird; Markku Qvarnström; Pekka Nuutinen; Leland K. Ackerson; J. Hong; P. Muthukrishnan; T. E. Van Dyke
Previous studies examined the serum immunoglobulin levels in relation to coronary artery disease (CAD). We hypothesized that the salivary immunoglobulins might better estimate oral infections in this relationship. Multivariate logistic regression analyses utilizing the data from 256 angiographically confirmed CAD patients and 250 non-CAD individuals that controlled for age, sex, smoking, diabetes, total/HDL cholesterol ratio, hypertension, and education revealed the trends that salivary IgA was positively and salivary IgG was inversely associated with CAD. The odds ratios (OR) of each increasing quartile of salivary IgA were 1.00 (first and second quartiles combined), 1.97, and 1.37 (p-value for trend = 0.06), while those for salivary IgG were 1.00, 0.77, 0.60, and 0.51 (p-value for trend = 0.02). Additionally, salivary IgA correlated positively with C-reactive protein and Asymptotic Dental Score (dental infection score), while IgG was inversely associated with these inflammation markers. Salivary IgA warrants further studies to confirm its role in the risk assessment of CAD.
Clinical Oral Investigations | 2007
Markku Qvarnström; Sok-Ja Janket; Pekka Nuutinen; Jussi Furuholm; Jukka H. Meurman
Data on saliva in coronary artery bypass graft (CABG) surgery patients are sparse. Understanding salivary parameters, however, may aid clinical decision making. We hypothesized that cardiac surgery might affect patients’ salivary flow rates and buffering, salivary proteins, and microbial counts. A 3-year, open follow-up study was conducted examining salivary flow, its chemical composition, and acidogenic microbial counts in 89 CABG surgery patients. The changes in salivary flow and proteins between baseline and 3-year post-CABG surgery were assessed using paired t-test and, with respect to the median of number of drugs used daily, by use of a nonparametric rank sum test. The results showed no long-term change in salivary flow rates and buffering capacity. With the exception of salivary urea, IgA and IgM concentration, and lysozyme output, the differences in salivary proteins between baseline and 3-year post-CABG were not statistically significant. No difference was observed in saliva values between patients taking drugs below or above the median number of drugs. Acidogenic microbial counts remained the same throughout the study. In conclusion, the salivary flow rates and constituents did not practically change in patients who underwent CABG surgery during the 3-year follow-up.
Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology | 2003
Jukka H. Meurman; Sok-Ja Janket; Markku Qvarnström; Pekka Nuutinen
Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology | 2003
Jukka H. Meurman; Markku Qvarnström; Sok-Ja Janket; Pekka Nuutinen
Journal of Periodontal Research | 2006
Jussi Furuholm; Timo Sorsa; Markku Qvarnström; Sok-Ja Janket; Taina Tervahartiala; Pekka Nuutinen; Jukka H. Meurman
Arteriosclerosis, Thrombosis, and Vascular Biology | 2005
Sok-Ja Janket; Jukka H. Meurman; Pekka Nuutinen; Markku Qvarnström; Martha E. Nunn; Alison E. Baird; Thomas E. Van Dyke; Judith A. Jones
Archive | 2011
Alison E. Baird; Thomas E. Van Dyke; Judith A. Jones; Sok-Ja Janket; Jukka H. Meurman; Pekka Nuutinen; Markku Qvarnström; E Martha
Atherosclerosis Supplements | 2007
Sok-Ja Janket; Jukka H. Meurman; Alison E. Baird; Markku Qvarnström; Pekka Nuutinen; T.E. Van Dyke